本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Lyra Therapeutics

0.0926
-0.0004-0.43%
盘后0.09390.0013+1.40%18:49 EDT
成交量:104.22万
成交额:9.64万
市值:610.05万
市盈率:-0.06
高:0.0967
开:0.0950
低:0.0900
收:0.0930
数据加载中...
2025/04/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/13

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/13

重要事件披露

Form 8-K - Current report
2025/03/13

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/01/10

重要事件披露

Form 8-K - Current report
2024/12/16

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/12/13

重要事件披露

Form 8-K - Current report
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/08/15

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/15

重要事件披露

Form 8-K - Current report
2024/07/23

重要事件披露

Form 8-K - Current report
2024/06/19

重要事件披露

Form 8-K - Current report
2024/06/07

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/05/21

重要事件披露

Form 8-K - Current report